Cargando…

Potential of chromatin modifying compounds for the treatment of Alzheimer's disease

Alzheimer's disease is a very common progressive neurodegenerative disorder affecting the learning and memory centers in the brain. The hallmarks of disease are the accumulation of β-amyloid neuritic plaques and neurofibrillary tangles formed by abnormally phosphorylated tau protein. Alzheimer&...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karagiannis, Tom C., Ververis, Katherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Co-Action Publishing 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417541/ https://www.ncbi.nlm.nih.gov/pubmed/22953035 http://dx.doi.org/10.3402/pba.v2i0.14980

Ejemplares similares

Evaluation of the efficacy of radiation-modifying compounds using γH2AX as a molecular marker of DNA double-strand breaks
por: Mah, Li-Jeen, et al.
Publicado: (2011)

Safety and Efficacy of Pralatrexate in the Management of Relapsed or Refractory Peripheral T-cell Lymphoma
por: Rodd, Annabelle L., et al.
Publicado: (2012)

Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay
por: Pitsillou, Eleni, et al.
Publicado: (2020)

Histone Deacetylase Inhibition and Dietary Short-Chain Fatty Acids
por: Licciardi, Paul V., et al.
Publicado: (2011)

Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
por: Ververis, Katherine, et al.
Publicado: (2013)

Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay
por: Pitsillou, Eleni, et al.
Publicado: (2021)

Investigation of molecular mechanisms of experimental compounds in murine models of chronic allergic airways disease using synchrotron Fourier-transform infrared microspectroscopy
por: Mazarakis, Nadia, et al.
Publicado: (2020)

Small molecule interactions with the SARS-CoV-2 main protease: In silico all-atom microsecond MD simulations, PELE Monte Carlo simulations, and determination of in vitro activity inhibition
por: Liang, Julia, et al.
Publicado: (2022)

Investigation of small molecule inhibitors of the SARS-CoV-2 papain-like protease by all-atom microsecond modelling, PELE Monte Carlo simulations, and in vitro activity inhibition
por: Liang, Julia J., et al.
Publicado: (2022)

Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro Enzymatic Activity Assay
por: Pitsillou, Eleni, et al.
Publicado: (2020)

Unveiling the Therapeutic Potentials of Mushroom Bioactive Compounds in Alzheimer’s Disease
por: Li, Na, et al.
Publicado: (2023)

Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes
por: Karagiannis, Tom C, et al.
Publicado: (2010)

The Role of Dietary Antioxidants and Their Potential Mechanisms in Alzheimer’s Disease Treatment
por: Knight, Emily, et al.
Publicado: (2023)

Phospho-Tau and Chromatin Landscapes in Early and Late Alzheimer’s Disease
por: Gil, Laura, et al.
Publicado: (2021)

Role of Natural Compounds and Target Enzymes in the Treatment of Alzheimer’s Disease
por: Wang, Shanshan, et al.
Publicado: (2022)

Tetrahydrohyperforin: a neuroprotective modified natural compound against Alzheimer's disease
por: Montecinos-Oliva, Carla, et al.
Publicado: (2015)

Sleep Disturbance as a Potential Modifiable Risk Factor for Alzheimer’s Disease
por: Minakawa, Eiko N., et al.
Publicado: (2019)

Disease-modifying drugs in Alzheimer’s disease
por: Ghezzi, Laura, et al.
Publicado: (2013)

Pomegranate: A Source of Multifunctional Bioactive Compounds Potentially Beneficial in Alzheimer’s Disease
por: Ciccone, Lidia, et al.
Publicado: (2023)

Disease-modifying treatments in Alzheimer’s disease
por: Edwards, Marc, et al.
Publicado: (2023)

Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease
por: Ettcheto, Miren, et al.
Publicado: (2019)

Identification of Chromatin Regulatory Factors Related to Immunity and Treatment of Alzheimer’s Disease
por: Xiong, Fengzhen, et al.
Publicado: (2023)

Antioxidant Compounds in the Treatment of Alzheimer's Disease: Natural, Hybrid, and Synthetic Products
por: Hatami, Maryam, et al.
Publicado: (2023)

Mdm2 as a chromatin modifier
por: Wienken, Magdalena, et al.
Publicado: (2017)

ANO10 Function in Health and Disease
por: Chrysanthou, Androniki, et al.
Publicado: (2022)

Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease
por: Bateman, Randall J., et al.
Publicado: (2022)

Therapeutic Potentials of Microalgae in the Treatment of Alzheimer’s Disease
por: Olasehinde, Tosin A., et al.
Publicado: (2017)

Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease
por: Naseem, Saira, et al.
Publicado: (2023)

Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease
por: Vicente-Zurdo, David, et al.
Publicado: (2022)

Bridging Cyanobacteria to Neurodegenerative Diseases: A New Potential Source of Bioactive Compounds against Alzheimer’s Disease
por: Castaneda, Andrea, et al.
Publicado: (2021)

Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer’s Disease and Parkinson’s Disease
por: Tapias, Victor, et al.
Publicado: (2023)

Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research
por: Yiannopoulou, Konstantina G., et al.
Publicado: (2019)

Connecting Chromatin Modifying Factors to DNA Damage Response
por: Lai, Weiwei, et al.
Publicado: (2013)

Chromatin‐modifying drugs and metabolites in cell fate control
por: Yao, Ziyue, et al.
Publicado: (2020)

Macroalgae as a Valuable Source of Naturally Occurring Bioactive Compounds for the Treatment of Alzheimer’s Disease
por: Olasehinde, Tosin A., et al.
Publicado: (2019)

Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease
por: Novakovic, Dijana, et al.
Publicado: (2013)

Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment
por: Atlante, Anna, et al.
Publicado: (2022)

Update on Disease-Modifying/Preventive Therapies in Alzheimer’s Disease
por: Apter, Jeffrey T., et al.
Publicado: (2015)

The Role of Selected Bioactive Compounds in the Prevention of Alzheimer’s Disease
por: Grodzicki, Wojciech, et al.
Publicado: (2020)

Marine-Derived Compounds with Anti-Alzheimer’s Disease Activities
por: Hafez Ghoran, Salar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_065gnhnnsao7ni11p87vjg836j